Immediate Impact
27 standout
Citing Papers
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Amber B. Clemmons being referenced
Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma
2022
Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Amber B. Clemmons | 87 | 67 | 57 | 36 | 307 | |
| Basma Merhi | 60 | 40 | 59 | 26 | 297 | |
| Sandra Manceau | 78 | 80 | 46 | 22 | 331 | |
| Rasha El‐Ashry | 64 | 39 | 45 | 24 | 279 | |
| Soheila Zareifar | 69 | 78 | 70 | 52 | 370 | |
| Vineet Kumar Kamal | 55 | 43 | 77 | 38 | 338 | |
| Francesca Tirelli | 67 | 47 | 31 | 36 | 360 | |
| Nathalie Garnier | 79 | 114 | 39 | 40 | 353 | |
| Gholamreza Bahoush | 47 | 77 | 60 | 40 | 256 | |
| İbrahim Bayram | 49 | 45 | 61 | 55 | 322 | |
| Julie Asch | 81 | 73 | 78 | 24 | 281 |
All Works
Login with ORCID to disown or claim papers
Loading papers...